These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
368 related items for PubMed ID: 7032534
21. [Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia]. Bucalossi A, Buzzelli G, D'Alessandro A. Clin Ter; 1979 Apr 30; 89(2):127-49. PubMed ID: 226307 [No Abstract] [Full Text] [Related]
22. [Comparison of the lipid-lowering agents clofibrate and bezafibrate in patients with hyperlipoproteinemias IIa and IIb]. Kokot F, Szczechowska E. Z Gesamte Inn Med; 1981 Jul 01; 36(13):454-7. PubMed ID: 7025475 [Abstract] [Full Text] [Related]
30. [Current trends in the therapy of arteriosclerotic disease]. Toscano S. G Clin Med; 1974 Jan 01; 55(1):27-39. PubMed ID: 4369524 [No Abstract] [Full Text] [Related]
31. The antilipemic effectiveness of aluminium clofibrate on hyperlipidemic patients with or without diabetes mellitus. Lam HC, Li SH, Wang JT, Tang KT, Ho LT. Zhonghua Yi Xue Za Zhi (Taipei); 1987 Nov 01; 40(5):463-70. PubMed ID: 3332236 [No Abstract] [Full Text] [Related]
33. [Bis-(hydroxy-2-ethylthyo)-1,10-decano in hyperlipaemic therapy (author's transl)]. Cucinotta D, Palummeri E, Ceccato S, Passeri M. G Ital Cardiol; 1977 Nov 01; 7(3):248-64. PubMed ID: 858465 [Abstract] [Full Text] [Related]
34. Clofibrate and related compounds in hyperlipoproteinaemia. A review. Gustafson A. Postgrad Med J; 1975 Nov 01; 51(8):suppl 66-71. PubMed ID: 215983 [No Abstract] [Full Text] [Related]
37. [Effect of bezafibrate on lipid and apoprotein levels in patients with idiopathic hypertriglyceridemia]. Naruszewicz M, Nowicka G, Szostak WB, Kłosiewicz-Latoszek L. Kardiol Pol; 1982 Nov 01; 25(7-8):527-31. PubMed ID: 7169740 [No Abstract] [Full Text] [Related]